Maruyama, R., Yamana, K., Itoi, T., Hara, N., Bilim, V., Nishiyama, T., . . . Tomita, Y. (2006). Absence of Bcl-2 and Fas/CD95/APO-1 predicts the response to immunotherapy in metastatic renal cell carcinoma. Nature Publishing Group.

Maruyama, R., K. Yamana, T. Itoi, N. Hara, V. Bilim, T. Nishiyama, K. Takahashi, و Y. Tomita. Absence of Bcl-2 and Fas/CD95/APO-1 Predicts the Response to Immunotherapy in Metastatic Renal Cell Carcinoma. Nature Publishing Group, 2006.

Maruyama, R., et al. Absence of Bcl-2 and Fas/CD95/APO-1 Predicts the Response to Immunotherapy in Metastatic Renal Cell Carcinoma. Nature Publishing Group, 2006.